EBR Systems Past Earnings Performance

Past criteria checks 0/6

EBR Systems's earnings have been declining at an average annual rate of -8.5%, while the Medical Equipment industry saw earnings growing at 5.6% annually.

Key information

-8.5%

Earnings growth rate

81.9%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth raten/a
Return on equity-112.8%
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Is EBR Systems (ASX:EBR) Using Debt In A Risky Way?

Mar 14
Is EBR Systems (ASX:EBR) Using Debt In A Risky Way?

Revenue & Expenses Breakdown
Beta

How EBR Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:EBR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-351421
30 Sep 230-341321
30 Jun 230-331320
31 Mar 230-331320
31 Dec 220-331421
30 Sep 220-361318
30 Jun 220-401316
31 Mar 220-401115
31 Dec 210-401013
30 Sep 210-33911
30 Jun 210-25710
31 Mar 210-26712
31 Dec 200-26713
31 Dec 191-25911

Quality Earnings: EBR is currently unprofitable.

Growing Profit Margin: EBR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EBR is unprofitable, and losses have increased over the past 5 years at a rate of 8.5% per year.

Accelerating Growth: Unable to compare EBR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EBR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: EBR has a negative Return on Equity (-112.82%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.